Uncategorized Archives - Market Newsdesk

ComEd, Metropolitan Mayor’s Caucus Spark Joy with 25 Grants Supporting Holiday Light Events

Fifth annual Powering the Holidays Grant Program Delivers Over $60,000 to Northern Illinois Communities

CHICAGO–(BUSINESS WIRE)–
As the holiday season draws near, ComEd and the Metropolitan Mayors Caucus are empowering communities across northern Illinois with grants to help light up the winter months with festive cheer. Through the annual Powering the Holidays grant program, 25 municipalities and nonprofit organizations will receive awards of up to $2,500 to support local holiday light displays and events that bring neighbors together in cultural celebrations.

“Holiday lights illuminate the spirit of our communities—shining as beacons of hope, unity, and shared joy,” said Melissa Washington, ComEd’s senior vice president of governmental, regulatory and external affairs. “ComEd’s commitment to northern Illinois goes beyond delivering reliable power. Through community light shows, ComEd helps foster connection, celebrate tradition, and showcase the cultural pride that makes neighborhoods we proudly serve so vibrant.”

Launched in 2021, the Powering the Holidays grant program has become a seasonal tradition that celebrates the culture and creativity of local communities. With this year’s awards, ComEd has invested a total of $234,000 in over 90 communities and organizations to help transform public spaces into dazzling winter wonderlands.

“This program continues to be a powerful way to showcase the heart and soul of our communities,” said Neil James, executive director of the Metropolitan Mayors Caucus. “Each light display tells a story of heritage, togetherness and the magic of the season. We’re proud to help make those stories shine.”

The grants will support events scheduled between Nov. 1, 2025, and Feb. 13, 2026. Eligible applicants included nonprofit organizations, municipalities, counties, townships and other local government entities within ComEd’s service area. ComEd provides funding for the program, while the Metropolitan Mayors Caucus administers grants after a third-party group of judges reviews applications.

Powering the Holidays grants will be awarded to the following communities and organizations in 2025:

Addison Township will expand its inaugural holiday celebration with illuminated figurines, dazzling light displays, and live performances that showcase local talent and cultural diversity. With grant support, the event will foster community pride and unity while laying the foundation for a lasting tradition that brings joy and vibrancy to the township each holiday season.

Ahead Academy will light up Chicago’s Bronzeville neighborhood with a culturally rooted holiday event that celebrates joy and brings families together for music, crafts, and community connection. With grant support, the event will feature sustainable lighting and decorations, hands-on activities, and a welcoming space that reflects and uplifts the neighborhood’s identity and youth voices.

City of Belvidere will enhance the reach and impact of its Hometown Christmas by contributing to event costs and the purchase of two trees—one for public display and one to be gifted to a family in need. This festive event will strengthen local connections and support families during the season through inclusive activities including ice skating, puppet shows, cookie decorating and more.

Village of Bensenville will celebrate its diverse community with a tree display decorated by local schools and cultural groups, alongside live entertainment and festive activities for all ages. Supported by grant funding for stage, lighting, and DJ services, the event will foster unity and joy through music, storytelling, and shared holiday traditions.

Calahan Foundation will host a community-centered holiday event in Chicago’s Englewood neighborhood featuring a tree lighting ceremony, ornament-making, hot cocoa, and a resource fair offering support services to families. With grant funding, the celebration will provide festive decorations, winter essentials, and engaging activities that bring warmth, joy, and connection to residents during the holiday season.

Calumet City will transform the grounds around city hall into a vibrant and colorful holiday destination with new energy-efficient LED lights in various styles and colors. Grant funding will support the purchase of durable lighting and decorations that enhance the Annual Tree Lighting Ceremony, creating a welcoming space for musical performances, family activities, and community connection.

Village of Carpentersville will enhance Triangle Park with new lighted features and a photo frame to make Winterville’s holiday wonderland even more magical and interactive for visitors of all ages. These additions will brighten the festive atmosphere and create memorable moments through music, crafts, and seasonal cheer.

Curie Metropolitan High School for the Performing & Technical Arts will stage “It’s A Wonderful Life The Musical” with upgraded lighting that enhances both the performance and behind-the-scenes learning. With support from grant funding, the production will offer hands-on experience in technical theatre, foster collaboration with community arts partners, and showcase student talent to families and the broader Chicago Public Schools community.

City of Evanston will light up local storefronts and public spaces in the historic Church and Dodge district with the Holiday Festival and Tree Lighting Ceremony through festive decorations, trolley rides, and live performances that celebrate the cultural heritage of the city’s Black community. With support from grant funding, the event will feature gospel and jazz music, interactive activities, and vibrant decorations that foster connection, highlight local businesses, and honor community traditions.

Village of Forest Park will illuminate 73 streetlamps and decorate its central Holiday Tree and surrounding trees with bright LED lights to create a glowing, festive atmosphere for the Holiday Walk. With grant support, these enhancements will guide attendees through decorated storefronts and community activities, culminating in Santa’s arrival and a joyful tree lighting ceremony that brings warmth and connection to the downtown district.

Village of Glenwood will enhance its annual tree lighting celebration with additional LED lighting, festive decorations, warm drinks, and live entertainment to create a welcoming and joyful experience for all. Grant support will help cover core event costs, allowing the village to introduce new elements like food trucks, small gifts for children, and interactive holiday displays that deepen community engagement.

Village of Grayslake will brighten its Festival of Lights with the addition of a lighted archway, decorative spheres, and string lights at the new gazebo, enhancing the experience for visitors of all ages. Supported by grant funding, these energy-efficient upgrades will replace older displays and elevate a beloved celebration filled with music, crafts, carriage rides, and the magical countdown to the tree lighting.

Village of Hazel Crest will install programmable LED lighting around its new Creative Arts Center to establish a vibrant, inclusive holiday display that celebrates multiple cultural traditions. By engaging local commissions and college artists, the project will foster community collaboration and enhance public spaces with energy-efficient, artistic lighting.

City of Joliet will light up its newly developed City Square with fresh holiday decorations as part of the annual Light Up the Holidays Festival, featuring a parade, family activities, and a tree lighting ceremony. Grant funding will support the purchase, installation, and maintenance of energy-efficient lights, helping to create a festive and welcoming atmosphere for all residents.

Village of Lake in the Hills will enhance its signature Flurry Fest and Holiday Lights Decorating Tour with improved lighting, decorations, and a reinstated community tree lighting ceremony to create a more immersive and festive experience. Community members can participate in a self-guided driving tour or register for a bus-guided tour sponsored by the Village.

Leyden Township will refresh its annual Community Tree Lighting Ceremony by purchasing new LED lights to brighten Westdale Park’s festive Christmas village. The upgraded display will enhance a beloved event filled with family-friendly activities, holiday treats, and a tree decorating contest that brings together the township in celebration.

Men of Purpose Mentoring will transform the Chicago Housing Authority’s Altgeld Gardens into a festive hub by decorating lamp posts and a central 30-foot tree and creating a vibrant holiday display that spans the neighborhood. The celebration will bring residents together with giveaways, refreshments, and joyful activities, fostering community pride and seasonal spirit.

Progressive West Rockford Community Development Corporation will expand its multi-block holiday display with more energy-efficient decorations, gifts for children, and a community celebration featuring lights, music, and festive activities. This resident-led initiative will continue to unite neighbors through creativity, joy, and shared holiday spirit, transforming public space into a beacon of connection and cheer.

Village of Sauk Village will extend its cherished Santa Parade and Tree-Lighting Ceremony by illuminating the path from the municipal center to Veterans Memorial Park with LED lights and festive trees. With support from grant funding, the event will feature decorated storefronts, hot chocolate, music, and community-crafted displays that foster connection and holiday spirit throughout the town.

Schiller Park Local Government will transform Irving Park Road into a festive corridor by installing 11 snowflake pole-mounted LED lighting displays as part of its Winter Wonderland celebration. With grant support, the village will install these energy-efficient decorations, helping to brighten public spaces and enhance a beloved seasonal event filled with crafts, games, and holiday cheer.

Village of Skokie will brighten its downtown with white LED string lights on key trees in municipal lots, creating a warm and inclusive winter atmosphere. Supported by grant funding, the project will complement existing seasonal decorations and coincide with the popular Downtown Skokie Cookie Walk, drawing hundreds of residents to enjoy festive sights and community spirit.

Village of South Chicago Heights will illuminate the Veteran’s Mound and surrounding public spaces with new LED holiday lighting and decorations for its 37th annual Tree Lighting Ceremony. The event will bring together residents of all ages with music, performances, and festive cheer, while recognizing student performers and creating lasting memories with a professional Santa experience.

Village of Steger will replace old, unsafe electrical wiring with new wiring and equipment that will be used for over 80 holiday trees and to create a safer walkway to Santa’s house, spotlights for the town’s annual holiday event, and lighting for a large tent where kids enjoy free games, cookies, and hot apple cider.

Rainbow Beach Park Advisory Council will enhance the South Shore Holiday Tree Trail & Toy Giveaway with decorated trees, energy-efficient lights, and a free community event. Supported by grant funding, the celebration will bring residents together with music, refreshments, and gifts for children, fostering connection and holiday cheer throughout the season.

City of Woodstock will install lighting across more than 120 shrubs, enhancing a festive atmosphere and creating a magical setting for carolers as well as themed attractions like the Gingerbread Walk and Christmas Tree Walk.

ComEd is a unit of Chicago-based Exelon Corporation (NASDAQ: EXC), a Fortune 200 company and one of the nation’s largest utility companies, serving more than 10.7 million electricity and natural gas customers. ComEd powers the lives of more than 4 million customers across northern Illinois, or 70 percent of the state’s population. For more information, visit ComEd.com, and connect with the company on Facebook, Instagram, LinkedIn, X and YouTube.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251022519037/en/

ComEd

Media Relations

312-394-3500

KEYWORDS: Illinois United States North America

INDUSTRY KEYWORDS: Urban Planning Fund Raising Professional Services Public Policy/Government Philanthropy Other Construction & Property Other Energy Utilities Construction & Property Oil/Gas Alternative Energy Energy Nuclear State/Local Environmental, Social and Governance (ESG) Other Professional Services Environment

MEDIA:

September 29, 2025 8:16 am

Phillips Edison & Company Inc. Invites You to Join Its Third Quarter 2025 Earnings Conference Call

CINCINNATI, Sept. 29, 2025 (GLOBE NEWSWIRE) — Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO” or the “Company”), one of the nation’s largest owners and operators of high-quality, grocery-anchored neighborhood shopping centers, will announce its Third Quarter 2025 earnings results on Thursday, October 23, 2025, after the market closes. PECO’s earnings release and supplemental information package will be posted on the Investor Relations section of the Company’s website at https://investors.phillipsedison.com/. Chairman and Chief Executive Officer Jeff Edison, President Bob Myers and Chief Financial Officer John Caulfield will host an earnings conference call, which will also be webcasted, on Friday, October 24, 2025, at 12:00 p.m. ET.

Third Quarter 2025 Earnings Conference Call Details:

Date: Friday, October 24, 2025
Time: 12:00 p.m. ET
Participant Toll-Free Dial-In Number: (800) 715-9871
Participant Toll Dial-In Number: +1 (646) 307-1963
Conference ID: 371251863
Webcast: Phillips Edison & Company, Inc. Q3 2025 Earnings Webcast

A webcast replay will be available approximately one hour after the conclusion of the presentation using the same link. Webcasts are archived on PECO’s Investor Relations website.

Connect with PECO

For additional information, please visit https://www.phillipsedison.com/

Follow PECO on:
X at https://x.com/PhillipsEdison
Facebook at https://www.facebook.com/phillipsedison.co
Instagram at https://www.instagram.com/phillips.edison/; and
Find PECO on LinkedIn at https://www.linkedin.com/company/phillipsedison&company

About Phillips Edison & Company

Phillips Edison & Company, Inc. (“PECO”) is one of the nation’s largest owners and operators of high-quality, grocery-anchored neighborhood shopping centers. Founded in 1991, PECO has generated strong results through its vertically-integrated operating platform and national footprint of well-occupied shopping centers. PECO’s centers feature a mix of national and regional retailers providing necessity-based goods and services in fundamentally strong markets throughout the United States. PECO’s top grocery anchors include Kroger, Publix, Albertsons and Ahold Delhaize. As of June 30, 2025, PECO managed 327 shopping centers, including 303 wholly-owned centers comprising 34.0 million square feet across 31 states and 24 shopping centers owned in three institutional joint ventures. PECO is focused on creating great omni-channel, grocery-anchored shopping experiences and improving communities, one neighborhood shopping center at a time.

PECO uses, and intends to continue to use, its Investors website, which can be found at https://investors.phillipsedison.com, as a means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation FD.

Investors:

Kimberly Green, Head of Investor Relations
(513) 692-3399, [email protected]

September 29, 2025 8:13 am

Altimmune Appoints Industry Veteran Christophe Arbet-Engels, M.D., PhD as Chief Medical Officer to Drive Next Phase of Clinical Development of Pemvidutide

Seasoned clinical leader to oversee Phase 3 development of pemvidutide in MASH

Dr. Arbet-Engels has led late-stage development, regulatory approvals and commercial launches for multiple successful franchises

GAITHERSBURG, Md., Sept. 29, 2025 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced the appointment of Christophe Arbet-Engels, MD, PhD as Chief Medical Officer, effective October 1, 2025. Dr. Arbet-Engels joins the Company with more than 30 years of experience spanning industry, academia and private practice, and will lead the ongoing clinical development of pemvidutide including the planned Phase 3 trial in metabolic dysfunction-associated steatohepatitis (MASH). He succeeds Scott Harris, M.D., who earlier this year informed the Company of his plans to retire from the position. Dr. Harris will remain with the Company as a Senior Strategic Advisor until February 2026.

“We are thrilled to welcome Christophe to the team at this crucial juncture in Altimmune’s evolution,” said Vipin K. Garg, Ph.D., President and CEO of Altimmune. “He brings a wealth of experience across mid- and late-stage clinical development, regulatory approvals and commercial launches that will be invaluable as we continue to advance pemvidutide and work toward our mission of establishing a new standard of care in the treatment of hepato-metabolic disorders. On behalf of the executive team and Board of Directors, I would also like to thank Scott for his instrumental contributions over the last six years. His oversight of the pemvidutide program through multiple INDs and clinical trials has positioned us well as we prepare to enter Phase 3 development in MASH.”

Dr. Arbet-Engels added, “I am proud to join the talented leadership team at Altimmune and excited to lead the development of a therapy as promising as pemvidutide. The data generated to date reinforces the highly differentiated profile of pemvidutide as well as its category-leading potential in MASH. With upcoming 48 week data from the IMPACT trial in MASH, as well as the ongoing Phase 2 trials in Alcohol Use Disorder and Alcohol-associated Liver Disease, pemvidutide presents an exciting opportunity to disrupt the treatment paradigm in three highly prevalent indications and potentially address multiple significant unmet medical needs. I look forward to working closely with Vipin and the rest of the team as we advance to the End-of-Phase 2 meeting with the FDA and continue working toward the initiation of the Phase 3 trial in MASH.”

Dr. Arbet-Engels joins Altimmune from X4 Pharmaceuticals (Nasdaq: XFOR), where he served as Chief Medical Officer since 2023. While at X4, he contributed extensively to the successful regulatory process for Xolremdi (mavorixafor), which was approved in 2024 for WHIM Syndrome, and led late-stage clinical programs for mavorixafor in Chronic Neutropenia. Previously, he was Chief Medical Officer at Neurogastrx, Millendo Therapeutics, and Poxel Pharmaceuticals, where he led the clinical development and approval in Japan of Twymeeg for diabetes. Earlier in his career, he held several senior-level medical and clinical positions including at Biogen, Boehringer Ingelheim Pharmaceuticals, Hoffmann-La Roche, Merck Research Laboratories, Aventis Pharmaceuticals, and Ligand Pharmaceuticals, where he led clinical development and registration, launch and lifecycle management efforts for a variety of products including LANTUS® and JARDIANCE®. Prior to his career in industry, Dr. Arbet-Engels served in educational roles at The Salk Institute for Biological Studies, University of Paris VI, and the Assistance Publique, Hospitals of Paris, and he currently serves as a Member of the Board of Tutors in Biochemical Sciences at Harvard University. Dr. Arbet-Engels received his MD and PhD in internal medicine and endocrinology/metabolism from the University of Paris, France, and completed his MBA at Rutgers University. He completed a postdoctoral fellowship in the Department of Medicine, Division of Endocrinology and Metabolism at the University of California, San Diego, and residencies in Endocrinology and Internal Medicine at Military Hospital Bégin, Paris and Assistance Publique, Hospitals of Paris, respectively.

Inducement Grant

In connection with being named as Chief Medical Officer, Dr. Arbet-Engels will receive, in the aggregate, options to purchase 450,000 shares of Altimmune’s common stock, and 150,000 restricted stock units (“RSUs”). The options will have an exercise price equal to the closing price of Altimmune’s common stock on October 1, 2025 (the “Grant Date”). Based on the closing price of Altimmune’s common stock on October 1, 2025, Altimmune would issue approximately 347,436 options as inducement awards under its 2018 Inducement Grant Plan, and the balance as incentive stock options under its 2017 Omnibus Incentive Plan. The final allocation of options between the 2018 Inducement Grant Plan and 2017 Omnibus Plan are subject to adjustment based on the closing price of Altimmune’s common stock on the Grant Date. One-fourth of the shares underlying the options will vest on the one-year anniversary of the Grant Date and thereafter 1/36th of the shares underlying the options will vest monthly, such that the shares underlying the options will be fully vested on the fourth anniversary of the Grant Date, in each case, subject to Dr. Arbet-Engels continued employment with Altimmune on such vesting dates.

One-fourth of the RSUs will vest on the one-year anniversary of the Grant Date and thereafter the RSUs will vest in three substantially equal annual installments, such that the RSUs will be fully vested on the fourth anniversary of the Grant Date, in each case, subject to Dr. Arbet-Engel’s continued employment with Altimmune on such vesting dates. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).

About Altimmune

Altimmune is a late clinical-stage biopharmaceutical company focused on developing novel peptide-based therapeutics for liver and cardiometabolic diseases. The Company’s lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of MASH, Alcohol Use Disorder (AUD), Alcohol-associated Liver Disease (ALD) and obesity. For more information, please visit www.altimmune.com.

Forward-Looking Statements

Any statements made in this press release related to the development or commercialization of pemvidutide, an investigational product candidate, and other business, regulatory and financial matters including without limitation, the timing of key milestones for the Company’s clinical assets, future plans or expectations for pemvidutide for the treatment of MASH, AUD, ALD and obesity, and the prospects for receiving regulatory approval or commercializing or selling any product or drug candidates, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In addition, when or if used in this press release, the words “may,” “could,” “should,” “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plan,” “predict” and similar expressions and their variants, as they relate to Altimmune, Inc. may identify forward-looking statements. The Company cautions that these forward-looking statements are subject to numerous assumptions, risks, and uncertainties, which change over time. Important factors that may cause actual results to differ materially from the results discussed in the forward-looking statements, or historical experience include risks and uncertainties, including risks relating to: delays in regulatory review, manufacturing and supply chain interruptions, access to clinical sites, enrollment, adverse effects on healthcare systems and disruption of the global economy; the reliability of the results of studies relating to human safety and possible adverse effects resulting from the administration of the Company’s product candidates; the Company’s ability to manufacture clinical trial materials on the timelines anticipated; and the success of future product advancements, including the success of future clinical trials. Further information on the factors and risks that could affect the Company’s business, financial conditions and results of operations are contained in the Company’s filings with the U.S. Securities and Exchange Commission, including under the heading “Risk Factors” in the Company’s most recent annual report on Form 10-K, quarterly report on Form 10-Q and the Company’s other filings with the SEC, which are available at www.sec.gov.

Follow @Altimmune, Inc. on

LinkedIn

Follow @AltimmuneInc on

X

Investor Contact:

Lee Roth
Burns McClellan
Phone: 646-382-3403
[email protected]

September 22, 2025 1:12 pm

The Gross Law Firm Notifies Charter Communications, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – CHTR

PR Newswire

NEW YORK
, Sept. 22, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Charter Communications, Inc. (NASDAQ: CHTR).

Shareholders who purchased shares of CHTR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/charter-communications-inc-loss-submission-form/?id=168413&from=4

CLASS PERIOD: This lawsuit is on behalf of all persons and entities who purchased or otherwise acquired Charter securities, purchased call options on Charter common stock, or sold put options on Charter common stock, between July 26, 2024, and July 24, 2025, inclusive.

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) the impact of the Affordable Connectivity Program (ACP) end was a material event the Company was unable to manage or promptly move beyond; (ii) the ACP end was actually having a sustaining impact on Internet customer declines and revenue; (iii) neither was the Company executing broader operations in a way that would compensate for, or overcome the impact, of the ACP ending; (iv) the Internet customer declines and broader failure of Charter’s execution strategy created much greater risks on business plans and earnings growth than reported; (v) accordingly, the Company had no reasonable basis to state the Company was successfully executing operations, managing causes of Internet customer declines, or provide overly optimistic statements about the long term trajectory of the Company and EBITDA growth; and (iv) as a result of the foregoing, defendants materially misled with, and/or lacked a reasonable basis for, their positive statements about the Company’s business, operations, outlook during the Class Period.

DEADLINE: October 14, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/charter-communications-inc-loss-submission-form/?id=168413&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of CHTR during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is October 14, 2025. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-gross-law-firm-notifies-charter-communications-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline–chtr-302562306.html

SOURCE The Gross Law Firm

September 22, 2025 1:07 pm

Replimune Group, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before September 22, 2025 to Discuss Your Rights – REPL

PR Newswire

NEW YORK
, Sept. 22, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Replimune Group, Inc. (NASDAQ: REPL).

Shareholders who purchased shares of REPL during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/replimune-group-inc-loss-submission-form-3/?id=168401&from=4

CLASS PERIOD:
November 22, 2024 to July 21, 2025

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) defendants recklessly overstated the IGNYTE trial’s prospects, given material issues that defendants knew or should have known of, which resulted in the FDA deeming the IGNYTE trial inadequate and not well-controlled; and (2) as a result, defendants’ statements about Replimune’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

DEADLINE: September 22, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/replimune-group-inc-loss-submission-form-3/?id=168401&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of REPL during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is September 22, 2025. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/replimune-group-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-september-22-2025-to-discuss-your-rights–repl-302562323.html

SOURCE The Gross Law Firm

September 22, 2025 1:04 pm

Tesla, Inc. Sued for Securities Law Violations – Contact The Gross Law Firm Before October 3, 2025 to Discuss Your Rights – TSLA

PR Newswire

NEW YORK
, Sept. 22, 2025 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Tesla, Inc. (NASDAQ: TSLA).

Shareholders who purchased shares of TSLA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/tesla-inc-loss-submission-form-2/?id=168409&from=4

CLASS PERIOD:
April 19, 2023 to June 22, 2025

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) Tesla overstated the effectiveness of its autonomous driving technology; (ii) there was thus a significant risk that the Company’s autonomous driving vehicles, including the Robotaxi, would operate dangerously and/or in violation of traffic laws; (iii) the foregoing increased the likelihood that Tesla would become subject to heightened regulatory scrutiny; (iv) accordingly, Tesla’s business and/or financial prospects were overstated; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times

DEADLINE: October 3, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/tesla-inc-loss-submission-form-2/?id=168409&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of TSLA during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is October 3, 2025. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

View original content to download multimedia:https://www.prnewswire.com/news-releases/tesla-inc-sued-for-securities-law-violations—contact-the-gross-law-firm-before-october-3-2025-to-discuss-your-rights–tsla-302562311.html

SOURCE The Gross Law Firm

September 20, 2025 12:03 pm

VFC INVESTOR NOTICE: V.F. Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

PR Newswire

SAN DIEGO
, Sept. 20, 2025 /PRNewswire/ — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of V.F. Corporation (NYSE: VFC) securities between October 30, 2023 and May 20, 2025, both dates inclusive (the “Class Period”), have until November 12, 2025 to seek appointment as lead plaintiff of the V.F. Corporation class action lawsuit. Captioned Brenton v. V.F. Corporation, No. 25-cv-02878 (D. Colo.), the V.F. Corporation class action lawsuit charges V.F. Corporation as well as certain of V.F. Corporation’s top current and former executives with violations of the Securities Exchange Act of 1934.

If you suffered substantial losses and wish to serve as lead plaintiff of the V.F. Corporation class action lawsuit, please provide your information here:

https://www.rgrdlaw.com/cases-v-f-corporation-class-action-lawsuit-vfc.html

You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected].

CASE ALLEGATIONS: V.F. Corporation, together with its subsidiaries, offers branded apparel, footwear, and accessories for men, women, and children.

The V.F. Corporation class action lawsuit alleges that defendants created the false impression that they possessed reliable information pertaining to V.F. Corporation’s projected revenue outlook and anticipated growth while also minimizing risk from seasonality and macroeconomic fluctuations. In truth, according to the complaint, V.F. Corporation’s optimistic reports of growth, cost-cutting measures, and overall claims of positive trajectory of the Vans brand fell short of reality; and, despite a significant inventory reset to begin the turnaround process under Reinvent, V.F. Corporation was apparently unable to find a path to Vans growth that did not require additional significant restructuring to create a potentially sustainable growth model.

The V.F. Corporation class action lawsuit further alleges that on May 21, 2025, V.F. Corporation reported its fourth quarter and full-year fiscal 2025 results, highlighting a significant decline in Vans’ growth trajectory, which faltered from an 8% loss the quarter before to a 20% loss in the fourth quarter, and noting such decline would continue through the next quarter. The complaint alleges that V.F. Corporation attributed its results and below-expectation guidance largely as “a direct effect of deliberately reduced revenue to eliminate unprofitable or unproductive businesses” and “an additional set of deliberate actions” already in place but previously unannounced. According to the complaint, V.F. Corporation further noted that, disregarding these deliberate actions, Vans would still have shown a “high single digit[]” revenue decline, suggesting growth slowed in comparison to the prior years’ sequential improvements irrespective of management’s new “deliberate actions.” The V.F. Corporation class action lawsuit alleges that on this news, the price of V.F. Corporation stock fell nearly 16%.

THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired V.F. Corporation securities during the Class Period to seek appointment as lead plaintiff in the V.F. Corporation class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the V.F. Corporation class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the V.F. Corporation class action lawsuit. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the V.F. Corporation class action lawsuit.

ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world’s leading law firms representing investors in securities fraud and shareholder litigation. Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors. In 2024, we recovered over $2.5 billion for investors in securities-related class action cases – more than the next five law firms combined, according to ISS. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs’ firms in the world, and the Firm’s attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information:

https://www.rgrdlaw.com/services-litigation-securities-fraud.html

Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.

Contact:
            Robbins Geller Rudman & Dowd LLP
            J.C. Sanchez, Jennifer N. Caringal
            655 W. Broadway, Suite 1900, San Diego, CA 92101
            800-449-4900
            [email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/vfc-investor-notice-vf-corporation-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-302561691.html

SOURCE Robbins Geller Rudman & Dowd LLP

August 27, 2025 7:42 pm

Class Action Filed Against Biohaven Ltd. (BHVN) – September 12, 2025 Deadline to Join – Contact The Gross Law Firm

NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Biohaven Ltd. (NYSE: BHVN).

Shareholders who purchased shares of BHVN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

https://securitiesclasslaw.com/securities/biohaven-ltd-loss-submission-form/?id=163675&from=3

CLASS PERIOD: March 24, 2023 to May 14, 2025

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) The company’s product candidate, troriluzole’s regulatory prospects as a treatment for SCA, and/or the sufficiency of data that Biohaven submitted in support of troriluzole’s regulatory approval for this indication, were overstated; (ii) BHV-7000’s efficacy and clinical prospects as a treatment for bipolar disorder were likewise overstated; (iii) all the foregoing, once revealed, was likely to have a significant negative impact on Biohaven’s business and financial condition; and (iv) as a result, defendants’ public statements were materially false and misleading at all relevant times.

DEADLINE: September 12, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/biohaven-ltd-loss-submission-form/?id=163675&from=3

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of BHVN during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is September 12, 2025. There is no cost or obligation to you to participate in this case.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

August 27, 2025 7:37 pm

Bloomberg 500 (B500) Index Adds Sixteen Securities Following Semi-Annual Reconstitution

PR Newswire

NEW YORK
, Aug. 27, 2025 /PRNewswire/ — Bloomberg Indices announced the following changes to the Bloomberg 500 (B500) Index effective prior to the open of trading on Thursday, September 11, to coincide with the semi-annual reconstitution of the index. The B500 contains the 500 most highly capitalized US companies weighted by float market cap, reflecting a market capitalization of $58.19 trillion.

Affirm Holdings, Inc. (AFRM), Astera Labs, Inc. (ALAB), The Carlyle Group, Inc. (CG), CyberArk Software, Ltd. (CYBR), EMCOR Group, Inc. (EME), Comfort Systems USA, Inc. (FIX), Insmed, Inc. (INSM), International Paper Company (IP), Jabil, Inc. (JBL), NiSource, Inc. (NI), NRG Energy, Inc. (NRG), Nutanix, Inc. (NTNX), Rocket Lab Corporation (RKLB), SoFi Technologies, Inc. (SOFI), Tapestry, Inc. (TPR), and Viking Holdings Ltd. (VIK) will enter the index. These equities span a variety of sectors, but Technology is most represented amongst this set, with Financial and Industrials directly following.

Changes to the B500 Index reflect the results of a purely rules-based index design focused on measuring markets with transparency and representativeness beyond market capitalization alone. As a result, the B500 mitigates potential biases and systematically evaluates potential members, which may lead to earlier additions of qualified companies when compared to indices using a committee-based approach.

Following is the list of membership changes:

Security Ticker	Security Name	BICS Sector	Index Event
AFRM UW	Affirm Holdings Inc	Financials	Addition
ALAB UW	Astera Labs Inc	Technology	Addition
CG UW	Carlyle Group Inc/The	Financials	Addition
FIX UN	Comfort Systems USA Inc	Industrials	Addition
CYBR UW	CyberArk Software Ltd	Technology	Addition
EME UN	EMCOR Group Inc	Industrials	Addition
INSM UW	Insmed Inc	Health Care	Addition
IP UN	International Paper Co	Materials	Addition
JBL UN	Jabil Inc	Technology	Addition
NI UN	NiSource Inc	Utilities	Addition
NRG UN	NRG Energy Inc	Utilities	Addition
NTNX UW	Nutanix Inc	Technology	Addition
RKLB UR	Rocket Lab Corp	Industrials	Addition
SOFI UW	SoFi Technologies Inc	Financials	Addition
TPR UN	Tapestry Inc	Consumer Discretionary	Addition
VIK UN	Viking Holdings Ltd	Consumer Discretionary	Addition
AKAM UW	Akamai Technologies Inc	Technology	Deletion
AMTM UN	Amentum Holdings Inc	Technology	Deletion
AVTR UN	Avantor Inc	Health Care	Deletion
ENTG UW	Entegris Inc	Technology	Deletion
EPAM UN	EPAM Systems Inc	Technology	Deletion
LINE UW	Lineage Inc	Real Estate	Deletion
MOH UN	Molina Healthcare Inc	Health Care	Deletion
RAL UN	Ralliant Corp	Industrials	Deletion
RVTY UN	Revvity Inc	Health Care	Deletion
SNDK UW	Sandisk Corp/DE	Technology	Deletion
SWK UN	Stanley Black & Decker Inc	Industrials	Deletion
SWKS UW	Skyworks Solutions Inc	Technology	Deletion
WLK UN	Westlake Corp	Materials	Deletion

The B500 is available to Terminal clients at {B500 INDEX <GO>}. All research and methodology for the indices are available at Bloombergindices.com.

About Bloomberg Index Services Limited
Bloomberg’s index team has a proven track record in creating industry-leading and bespoke indices across asset classes, including their flagship fixed income, commodity and equity indices. Bloomberg Index Services Limited (BISL) takes an innovative approach to delivering strategic benchmarks that help market participants address their evolving investment needs. The indices, which are seamlessly integrated with other Bloomberg solutions, draw on a comprehensive range of trusted data and reliable technology for calculations, analytics and workflow automation, along with distribution capabilities that can help amplify the visibility of our customers’ products.

About Bloomberg
Bloomberg is a global leader in business and financial information, delivering trusted data, news, and insights that bring transparency, efficiency, and fairness to markets. The company helps connect influential communities across the global financial ecosystem via reliable technology solutions that enable our customers to make more informed decisions and foster better collaboration. For more information, visit Bloomberg.com/company or request a demo.

Category: Uncategorized

Faraday Future Announces Strategic Cooperation with RAK Motors to Oversee FX Super One Sales and Services in the UAE, Building a Complete Production-to-Service Ecosystem In the UAE

ComEd, Metropolitan Mayor’s Caucus Spark Joy with 25 Grants Supporting Holiday Light Events

Phillips Edison & Company Inc. Invites You to Join Its Third Quarter 2025 Earnings Conference Call

Altimmune Appoints Industry Veteran Christophe Arbet-Engels, M.D., PhD as Chief Medical Officer to Drive Next Phase of Clinical Development of Pemvidutide

The Gross Law Firm Notifies Charter Communications, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – CHTR

Replimune Group, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before September 22, 2025 to Discuss Your Rights – REPL

Tesla, Inc. Sued for Securities Law Violations – Contact The Gross Law Firm Before October 3, 2025 to Discuss Your Rights – TSLA

VFC INVESTOR NOTICE: V.F. Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Class Action Filed Against Biohaven Ltd. (BHVN) – September 12, 2025 Deadline to Join – Contact The Gross Law Firm

Bloomberg 500 (B500) Index Adds Sixteen Securities Following Semi-Annual Reconstitution